Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Net Income - Minority (2016 - 2019)

Historic Net Income - Minority for Fortress Biotech (FBIO) over the last 5 years, with Q1 2019 value amounting to -$29.9 million.

  • Fortress Biotech's Net Income - Minority changed N/A to -$29.9 million in Q1 2019 from the same period last year, while for Mar 2019 it was -$29.9 million, marking a year-over-year change of. This contributed to the annual value of -$17.9 million for FY2018, which is 7366.22% up from last year.
  • As of Q1 2019, Fortress Biotech's Net Income - Minority stood at -$29.9 million.
  • Fortress Biotech's 5-year Net Income - Minority high stood at -$17.9 million for Q4 2018, and its period low was -$67.9 million during Q4 2017.
  • For the 5-year period, Fortress Biotech's Net Income - Minority averaged around -$41.0 million, with its median value being -$44.5 million (2016).
  • Per our database at Business Quant, Fortress Biotech's Net Income - Minority plummeted by 6215.04% in 2016 and then skyrocketed by 7366.22% in 2018.
  • Fortress Biotech's Net Income - Minority (Quarter) stood at -$27.4 million in 2015, then plummeted by 62.15% to -$44.5 million in 2016, then tumbled by 52.74% to -$67.9 million in 2017, then surged by 73.66% to -$17.9 million in 2018, then plummeted by 67.08% to -$29.9 million in 2019.
  • Its Net Income - Minority was -$29.9 million in Q1 2019, compared to -$17.9 million in Q4 2018 and -$46.9 million in Q3 2018.